Pete Cotter

Company: Verve Therapeutics

Job title: Director

Seminars:

Panel Discussion: AAV, LNP, and the Implications for In Vivo Delivery Analytical Testing Requirements 4:00 pm

Generating robust analytical data for your delivery vehicle to bridge the gap between in vitro and in vivo studies Highlighting key analytical challenges for AAV and LNP delivery of gene editing therapies Developing an effective safety assessment to identify toxicities related to the delivery methodRead more

day: Conference Day Two